Cite
HARVARD Citation
Kang, D. et al. (2015). Absolute change in fasting plasma glucose over 12 months is associated with 2-year and 5-year major adverse cardiovascular events in patients with drug-eluting stent implants. International journal of cardiology. pp. 146-152. [Online].